GREG CHANCE: Open Payments
NPI 1124074877 · YUBA CITY, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,312 in 79 payments from 14 companies in 2025. Trend: 2023 $1,886 · 2024 $2,684 · 2025 $5,312
Consulting: $3,838Food & beverage: $1,474
| Company | Payments | Amount |
|---|---|---|
| Arcutis Biotherapeutics, Inc. | 27 | $4,328 |
| E.R. Squibb & Sons, L.L.C. | 8 | $198 |
| UCB, Inc. | 13 | $174 |
| ABBVIE INC. | 12 | $154 |
| PFIZER INC. | 1 | $95 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $78 |
| Organon LLC | 4 | $66 |
| Amgen Inc. | 2 | $47 |
| Regeneron Healthcare Solutions, Inc. | 2 | $47 |
| Verrica Pharmaceuticals Inc. | 2 | $43 |
Products named: Zoryve, Sotyktu, Bimzelx, SKYRIZI, LITFULO, VTAMA, Otezla, BLU-U.
Industry payments across CA — which companies pay providers there.
